• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer.

作者信息

Almquist Daniel R, Savvides Panayiotis, Ernani Vinicius

机构信息

. Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, Arizona, USA.

出版信息

J Bras Pneumol. 2021 Jul 12;47(3):e20210230. doi: 10.36416/1806-3756/e20210230.

DOI:10.36416/1806-3756/e20210230
PMID:34259787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8332728/
Abstract
摘要

相似文献

1
The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer.辅助化疗在可切除非小细胞肺癌中不可小觑的作用
J Bras Pneumol. 2021 Jul 12;47(3):e20210230. doi: 10.36416/1806-3756/e20210230.
2
Adjuvant chemotherapy for resected non-small cell lung cancer.可切除非小细胞肺癌的辅助化疗
J Thorac Oncol. 2006 Feb;1(2):180-7.
3
Adjuvant chemotherapy for surgically resected non-small cell lung cancer.手术切除的非小细胞肺癌的辅助化疗。
J Thorac Cardiovasc Surg. 2012 Sep;144(3):S39-42. doi: 10.1016/j.jtcvs.2012.03.039. Epub 2012 Apr 13.
4
Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.可切除II期非小细胞肺癌的辅助化疗：评估剂量强度和治疗时间的影响
Clin Oncol (R Coll Radiol). 2015 Jul;27(7):394-400. doi: 10.1016/j.clon.2015.03.001. Epub 2015 Mar 19.
5
[The role of adjuvant chemotherapy in non-small-cell lung cancer. Against].
Suppl Tumori. 2004 Jul-Aug;3(4):S45-7.
6
[Adjuvant therapy in non-small-cell lung cancer. For].
Suppl Tumori. 2004 Jul-Aug;3(4):S48-9.
7
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].[非小细胞肺癌的术后辅助化疗]
Gan To Kagaku Ryoho. 2005 Jun;32(6):765-9.
8
[Current status of adjuvant chemotherapy for the resected non-small cell lung cancer].[可切除非小细胞肺癌辅助化疗的现状]
Nihon Rinsho. 2002 May;60 Suppl 5:329-34.
9
[Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].[手术切除的非小细胞肺癌术后辅助治疗的疗效——一项基于证据的综述]
Gan To Kagaku Ryoho. 2006 Mar;33(3):300-6.
10
Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.完全切除的非小细胞肺癌术后辅助全身治疗：一项系统评价
Clin Lung Cancer. 2017 May;18(3):259-273.e8. doi: 10.1016/j.cllc.2016.07.002. Epub 2016 Jul 12.

本文引用的文献

1
Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.辅助化疗对非小细胞肺癌患者的有效性和毒性。
J Bras Pneumol. 2021 Feb 24;47(3):e20200378. doi: 10.36416/1806-3756/e20200378. eCollection 2021.
2
Osimertinib in Resected -Mutated Non-Small-Cell Lung Cancer.奥希替尼治疗可切除突变型非小细胞肺癌。
N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19.
3
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.培美曲塞联合顺铂对比长春瑞滨联合顺铂用于完全切除的Ⅱ期至ⅢA期非鳞状非小细胞肺癌的随机Ⅲ期研究
J Clin Oncol. 2020 Jul 1;38(19):2187-2196. doi: 10.1200/JCO.19.02674. Epub 2020 May 14.
4
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.辅助化疗联合或不联合贝伐单抗用于可切除的非小细胞肺癌患者（E1505）：一项开放标签、多中心、随机、3期试验。
Lancet Oncol. 2017 Dec;18(12):1610-1623. doi: 10.1016/S1470-2045(17)30691-5. Epub 2017 Nov 9.
5
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.辅助性紫杉醇加卡铂与ⅠB期非小细胞肺癌观察治疗的比较：癌症和白血病B组、放射治疗肿瘤学组及北中部癌症治疗组研究组的CALGB 9633研究
J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22.
6
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.完全切除的ⅠB-ⅢA期非小细胞肺癌患者辅助使用长春瑞滨加顺铂与观察对比（辅助长春瑞滨国际试验协作组[ANITA]）：一项随机对照试验
Lancet Oncol. 2006 Sep;7(9):719-27. doi: 10.1016/S1470-2045(06)70804-X.
7
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.长春瑞滨联合顺铂与观察等待治疗可切除非小细胞肺癌的疗效比较
N Engl J Med. 2005 Jun 23;352(25):2589-97. doi: 10.1056/NEJMoa043623.
8
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.在东部肿瘤协作组（ECOG）的E3590试验中，对II期和IIIA期非小细胞肺癌（NSCLC）进行切除术后的术后放疗（PORT）或放化疗（CPORT），并不会增加因并发疾病（DID）导致的预期死亡风险。
Lung Cancer. 2005 Jun;48(3):389-97. doi: 10.1016/j.lungcan.2004.11.007. Epub 2005 Jan 5.
9
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.完全切除的Ⅰ期、Ⅱ期或ⅢA期非小细胞肺癌辅助化疗的随机研究
J Natl Cancer Inst. 2003 Oct 1;95(19):1453-61. doi: 10.1093/jnci/djg059.